tiprankstipranks
Advertisement
Advertisement
LXEO Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsLXEO Upcoming Earnings Report: What to Expect?
2M ago
Controversial Prasad leaving FDA, NYT reports
Premium
The Fly
Controversial Prasad leaving FDA, NYT reports
2M ago
Lexeo Therapeutics Announces Head of Research Transition
Premium
Company Announcements
Lexeo Therapeutics Announces Head of Research Transition
3M ago
Lexeo Therapeutics Reports Positive Interim HEROIC-PKP2 Trial Results
PremiumCompany AnnouncementsLexeo Therapeutics Reports Positive Interim HEROIC-PKP2 Trial Results
4M ago
Lexeo Therapeutics Inc trading resumes
Premium
The Fly
Lexeo Therapeutics Inc trading resumes
4M ago
Lexeo Therapeutics Inc trading halted, volatility trading pause
Premium
The Fly
Lexeo Therapeutics Inc trading halted, volatility trading pause
4M ago
Tenaya Therapeutics price target lowered to $8 from $9 at Chardan
PremiumThe FlyTenaya Therapeutics price target lowered to $8 from $9 at Chardan
5M ago
Lexeo Therapeutics initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Lexeo Therapeutics initiated with an Overweight at Cantor Fitzgerald
5M ago
Lexeo Therapeutics initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Lexeo Therapeutics initiated with an Overweight at Cantor Fitzgerald
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100